A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
NCT06692738
This study is recruiting at 61 US sites in 30 states, according to its ClinicalTrials.gov record last updated .
Summary
The purpose of ARTEMIDE-Lung02 is to assess the efficacy and safety of rilvegostomig in combination with platinum-based chemotherapy for the first-line (1L) treatment of patients with locally advanced or metastatic squamous non-small cell lung cancer (mNSCLC) whose tumors express programmed death-ligand 1 (PD-L1).
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Non-small Cell Lung Cancer
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Phase 3
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Sponsor
- AstraZeneca
- Last updated on ClinicalTrials.gov
- September 18, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Arizona · 1
- Research Site · Tucson, AZ
Arkansas · 1
- Research Site · Springdale, AR
California · 7
- Research Site · Anaheim, CA
- Research Site · Beverly Hills, CA
- Research Site · Loma Linda, CA
- Research Site · Los Alamitos, CA
- Research Site · Redlands, CA
- Research Site · San Francisco, CA
- Research Site · Walnut Creek, CA
Connecticut · 1
- Research Site · West Haven, CT
Delaware · 1
- Research Site · Newark, DE
Florida · 4
- Research Site · Bay Pines, FL
- Research Site · Fort Lauderdale, FL
- Research Site · Gainesville, FL
- Research Site · Jacksonville, FL
Georgia · 1
- Research Site · Athens, GA
Idaho · 1
- Research Site · Boise, ID
Illinois · 4
- Research Site · Chicago, IL
- Research Site · Decatur, IL
- Research Site · Hinsdale, IL
- Research Site · Quincy, IL
Iowa · 1
- Research Site · Waterloo, IA
Kentucky · 3
- Research Site · Lexington, KY
- Research Site · Louisville, KY
- Research Site · Louisville, KY
Louisiana · 3
- Research Site · Baton Rouge, LA
- Research Site · Shreveport, LA
- Research Site · Shreveport, LA
Maine · 1
- Research Site · Scarborough, ME
Maryland · 1
- Research Site · Bethesda, MD
Michigan · 2
- Research Site · Detroit, MI
- Research Site · Grand Rapids, MI
Minnesota · 2
- Research Site · Duluth, MN
- Research Site · Rochester, MN
Missouri · 2
- Research Site · Bridgeton, MO
- Research Site · Kansas City, MO
Nebraska · 1
- Research Site · Lincoln, NE
New Jersey · 1
- Research Site · Camden, NJ
New York · 3
- Research Site · Buffalo, NY
- Research Site · East Syracuse, NY
- Research Site · Westbury, NY
North Carolina · 1
- Research Site · Wilson, NC
North Dakota · 1
- Research Site · Grand Forks, ND
Ohio · 1
- Research Site · Cincinnati, OH
Oregon · 2
- Research Site · Medford, OR
- Research Site · Salem, OR
Pennsylvania · 2
- Research Site · Hershey, PA
- Research Site · York, PA
South Dakota · 1
- Research Site · Sioux Falls, SD
Tennessee · 2
- Research Site · Chattanooga, TN
- Research Site · Nashville, TN
Texas · 4
- Research Site · Fort Worth, TX
- Research Site · Kingwood, TX
- Research Site · Lubbock, TX
- Research Site · Round Rock, TX
Virginia · 2
- Research Site · Fairfax, VA
- Research Site · Fredericksburg, VA
Washington · 4
- Research Site · Olympia, WA
- Research Site · Seattle, WA
- Research Site · Spokane, WA
- Research Site · Tacoma, WA
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.